MENOPUR (menotropins)
FOLLICLE-STIMULATING HORMONE (FSH) · FOLLICLE STIMULATION FOR ASSISTED FERTILIZATION PROCEDURE
FERRING PH INC
Drug class
Luteinizing Hormones (hLH)
Luteinizing hormones (hLH) are therapeutic glycoprotein gonadotropins that mimic endogenous luteinizing hormone. Read more about Luteinizing Hormones (hLH)
1 drugs in this class 1 manufacturers
Drugs in Luteinizing Hormones (hLH)
Filter & compare in the drug finder →
Opens the drug finder with Luteinizing Hormones (hLH) preselected. Add indication or manufacturer filters there.
Luteinizing hormones (hLH) are therapeutic glycoprotein gonadotropins that mimic endogenous luteinizing hormone.
While "Luteinizing Hormones (hLH)" is not a standard formal pharmacologic class name under FDA Established Pharmacologic Class designations, it describes pharmaceutical preparations—most notably recombinant human luteinizing hormone (lutropin alfa)—classified pharmacologically under gonadotropins and ovulation stimulants.
Pharmacodynamically, these agents bind to luteinizing hormone/choriogonadotropin receptors on ovarian theca cells to stimulate androgen production, which adjacent granulosa cells convert into estradiol, thereby supporting follicle-stimulating hormone-induced follicular development and preparing the reproductive tract for ovulation and implantation.
Therapeutics in this class are indicated in reproductive endocrinology, specifically for female infertility due to severe hypogonadotropic hypogonadism, where they are co-administered with follicle-stimulating hormone to stimulate follicular development.
-
fda.gov
Luteinizing hormones (hLH) are therapeutic glycoprotein gonadotropins that mimic endogenous luteinizing hormone While "Luteinizing Hormones (hLH)" is not a standard formal pharmacologic class name under FDA Established Pharmacologic Class designations, it describes pharmaceutical preparations—most notably recombinant human luteinizing hormone (lutropin alfa)—classified pharmacologically under gonadotropins and ovulation stimulants Pharmacodynamically, these agents bind to luteinizing hormone/cho...
-
fda.gov
Luteinizing hormones (hLH) are therapeutic glycoprotein gonadotropins that mimic endogenous luteinizing hormone Therapeutics in this class are indicated in reproductive endocrinology, specifically for female infertility due to severe hypogonadotropic hypogonadism, where they are co-administered with follicle-stimulating hormone to stimulate follicular development
-
fda.gov
While "Luteinizing Hormones (hLH)" is not a standard formal pharmacologic class name under FDA Established Pharmacologic Class designations, it describes pharmaceutical preparations—most notably recombinant human luteinizing hormone (lutropin alfa)—classified pharmacologically under gonadotropins and ovulation stimulants
-
fda.gov
While "Luteinizing Hormones (hLH)" is not a standard formal pharmacologic class name under FDA Established Pharmacologic Class designations, it describes pharmaceutical preparations—most notably recombinant human luteinizing hormone (lutropin alfa)—classified pharmacologically under gonadotropins and ovulation stimulants Therapeutics in this class are indicated in reproductive endocrinology, specifically for female infertility due to severe hypogonadotropic hypogonadism, where they are co-admini...
-
nih.gov
Pharmacodynamically, these agents bind to luteinizing hormone/choriogonadotropin receptors on ovarian theca cells to stimulate androgen production, which adjacent granulosa cells convert into estradiol, thereby supporting follicle-stimulating hormone-induced follicular development and preparing the reproductive tract for ovulation and implantation
-
fda.gov
Therapeutics in this class are indicated in reproductive endocrinology, specifically for female infertility due to severe hypogonadotropic hypogonadism, where they are co-administered with follicle-stimulating hormone to stimulate follicular development
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.